Genmab A (GMAB) Interest Coverage Ratio (2019 - 2026)
Genmab A's (GMAB) quarterly Interest Coverage Ratio came in at 2.7 in Q2 2026, up 34.03% on a YoY basis from 2.01 in Q2 2025, and down 124.82% quarter-over-quarter from 1.2 in Q1 2026.
Powered by 
Analysis
Genmab A (GMAB) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Genmab A (GMAB) has reported Interest Coverage Ratio for 8 consecutive years, with 2.7 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Interest Coverage Ratio rose 34.03% year-over-year to 2.7; the trailing twelve-month figure through Jun 2026 stood at 3.56 (down 49.3% YoY), and the FY2025 full-year result was 3.96, up 216.77% from the prior year.
- Interest Coverage Ratio eased to 2.7 in Q2 2026 per GMAB's latest filing, from 1.2 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 11.33 in Q4 2023 and bottomed at 41.88 in Q3 2023.
- Historically, Interest Coverage Ratio has averaged 5.05 across 5 years, with a median of 3.66 in 2024.
- The widest YoY moves for Interest Coverage Ratio: up 91.27% in 2024, down 953.09% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 3.68 in 2022, then soared by 408.14% to 11.33 in 2023, then plunged by 132.27% to 3.66 in 2024, then sank by 61.96% to 5.92 in 2025, then jumped by 54.46% to 2.7 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 2.7, 1.2, and 5.92 for Q2 2026, Q1 2026, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 117.59 |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | - |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 493.00 |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | - |
| 10 | Genmab A | 2.23 Bn | 728.64 Mn | 1.07 Bn | 2.70 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.70 |
| Mar 31, 2026 | -1.20 |
| Sep 30, 2025 | -5.92 |
| Jun 30, 2025 | -4.09 |
| Mar 31, 2025 | -4.18 |
| Sep 30, 2024 | -3.66 |
| Jun 30, 2024 | -4.11 |
| Mar 31, 2024 | -3.31 |
| Dec 31, 2023 | 11.33 |
| Sep 30, 2023 | -41.88 |
| Jun 30, 2023 | -2.70 |
| Mar 31, 2023 | 0.39 |
| Jun 30, 2022 | -3.68 |
| Dec 31, 2021 | -1.83 |
| Sep 30, 2021 | -3.87 |
| Jun 30, 2021 | -1.83 |
| Mar 31, 2021 | -17.74 |
| Dec 31, 2020 | -21.31 |
| Sep 30, 2020 | 0.00 |
| Jun 30, 2020 | -19.51 |